Announcements Trials

Browse Landscape

Phase

Status

Completed 53 Terminated 19 Recruiting 19 Unknown 12 Active not recruiting 6 Not yet recruiting 5 Withdrawn 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 29 Magnetic Resonance Spectroscopy 18 Biopsy 16 Cyclophosphamide 15 Nivolumab 10 Paclitaxel 9 Vincristine 8 Cisplatin 8 venetoclax 7 Prednisone 7 Gemcitabine 7 Doxorubicin 7 Bevacizumab 7 Azacitidine 7 pembrolizumab 6 Radiotherapy 6 Fluorouracil 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Rituximab 5 Radiosurgery 5 Oxaliplatin 5 Irinotecan 5 Injections 5 Everolimus 5 Capecitabine 5 fludarabine phosphate 4 Taxes 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Interventional × IFL protocol × Clear all

NCT05419479 2026-02-24

Switch Maintenance in Pancreatic

Dana-Farber Cancer Institute

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡